Cargando…

The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma

Background: Renal cell carcinoma (RCC) is the most common malignancy in the urinary system. Despite substantial improvements in available treatment options, the survival outcome of advanced RCC is unsatisfactory. Identifying novel biomarkers to assist in early diagnosis and to screen patients who ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Keying, Xu, Chao, Liu, Shaojie, Jiang, Yao, Zhao, Xiaolong, Ma, Shanjin, Li, Yu, Yang, Fa, Wang, Yan, Meng, Ping, Shi, Changhong, Han, Donghui, Wen, Weihong, Qin, Weijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006336/ https://www.ncbi.nlm.nih.gov/pubmed/33791227 http://dx.doi.org/10.3389/fonc.2021.644612

Ejemplares similares

CD248(+) Cancer-Associated Fibroblasts: A Novel Prognostic and Therapeutic Target for Renal Cell Carcinoma
por: Xu, Chao, et al.
Publicado: (2021)

Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder
por: Li, Yu, et al.
Publicado: (2021)

CD248 as a bridge between angiogenesis and immunosuppression: a promising prognostic and therapeutic target for renal cell carcinoma
por: Liu, Shaojie, et al.
Publicado: (2021)

Antibody-drug conjugates targeting CD248 inhibits liver fibrosis through specific killing on myofibroblasts
por: Liu, Shaojie, et al.
Publicado: (2022)

CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation
por: Lu, Shiqi, et al.
Publicado: (2023)

Prognostic value and underlying mechanism of autophagy-related genes in bladder cancer
por: Peng, Shiyuan, et al.
Publicado: (2022)

Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma
por: Gan, Kai, et al.
Publicado: (2022)

CD70 in Thymic Squamous Cell Carcinoma: Potential Diagnostic Markers and Immunotherapeutic Targets
por: Kashima, Jumpei, et al.
Publicado: (2022)

Cd248a and Cd248b in zebrafish participate in innate immune responses
por: Li, Xianpeng, et al.
Publicado: (2022)

Cancel cancer: The immunotherapeutic potential of CD200/CD200R blockade
por: Choe, Deborah, et al.
Publicado: (2023)

Endosialin-positive tumor-derived pericytes promote tumor progression through impeding the infiltration of CD8(+) T cells in clear cell renal cell carcinoma
por: Lu, Tong, et al.
Publicado: (2023)

Correction to: Endosialin‑positive tumor‑derived pericytes promote tumor progression through impeding the infiltration of CD8(+) T cells in clear cell renal cell carcinoma
por: Lu, Tong, et al.
Publicado: (2023)

The higher levels of self-reported satisfaction, the lower risk of depressive symptoms: Evidence from a nationwide cross-sectional study in China
por: Niu, Zhiping, et al.
Publicado: (2022)

An enhancer RNA-based risk model for prediction of bladder cancer prognosis
por: Xu, Zhicheng, et al.
Publicado: (2022)

Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues
por: Zhang, Jiayu, et al.
Publicado: (2022)

Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma
por: Dong, Xubin, et al.
Publicado: (2021)

Immunotherapeutic Advancements for Glioblastoma
por: Ampie, Leonel, et al.
Publicado: (2015)

Interference in melanoma CD248 function reduces vascular mimicry and metastasis
por: Kuo, Cheng-Hsiang, et al.
Publicado: (2022)

Immunotherapeutic Potential of Oncolytic Vaccinia Virus
por: Thorne, Steve H.
Publicado: (2014)

Experiences and Expectations for Glioma Immunotherapeutic Approaches
por: Yamanaka, Ryuya, et al.
Publicado: (2014)

Immunotherapeutic Potential of T Memory Stem Cells
por: Li, Yujie, et al.
Publicado: (2021)

Methods for Establishing a Renal Cell Carcinoma Tumor Spheroid Model With Immune Infiltration for Immunotherapeutic Studies
por: Lugand, Leonard, et al.
Publicado: (2022)

Attenuated Bacteria as Immunotherapeutic Tools for Cancer Treatment
por: Kaimala, Suneesh, et al.
Publicado: (2018)

Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy
por: Meyers, Daniel E., et al.
Publicado: (2017)

Identification and validation of a novel phagocytosis regulators-related signature with potential prognostic and immunotherapeutic value in patients with lung adenocarcinoma
por: Li, Jingyang, et al.
Publicado: (2022)

CD248: A therapeutic target in cancer and fibrotic diseases
por: Teicher, Beverly A.
Publicado: (2019)

Genetic Deletion of the Stromal Cell Marker CD248 (Endosialin) Protects against the Development of Renal Fibrosis
por: Smith, Stuart William, et al.
Publicado: (2016)

Glioma Stem Cells as Immunotherapeutic Targets: Advancements and Challenges
por: Piper, Keenan, et al.
Publicado: (2021)

Immunotherapeutic Strategies in Chronic Lymphocytic Leukemia: Advances and Challenges
por: Perutelli, Francesca, et al.
Publicado: (2022)

Targeting mutant p53-R248W reactivates WT p53 function and alters the onco-metabolic profile
por: Brown, Kate, et al.
Publicado: (2023)

The Gain-of-Function p53 R248W Mutant Promotes Migration by STAT3 Deregulation in Human Pancreatic Cancer Cells
por: Klemke, Luisa, et al.
Publicado: (2021)

Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors
por: Ortiz, Michael V., et al.
Publicado: (2019)

T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?
por: Zhou, Qi, et al.
Publicado: (2020)

CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma
por: Sussman, Robyn T., et al.
Publicado: (2020)

Targeting Versican as a Potential Immunotherapeutic Strategy in the Treatment of Cancer
por: Hirani, Priyanka, et al.
Publicado: (2021)

CD248 facilitates tumor growth via its cytoplasmic domain
por: Maia, Margarida, et al.
Publicado: (2011)

CD248 as a novel therapeutic target in pulmonary arterial hypertension
por: Xu, Tao, et al.
Publicado: (2020)

Sex-specific effects of CD248 on metabolism and the adipose tissue lipidome
por: Patrick, Kieran, et al.
Publicado: (2023)

Identification of Target PTEN-Based miR-425 and miR-576 as Potential Diagnostic and Immunotherapeutic Biomarkers of Colorectal Cancer With Liver Metastasis
por: Hu, Xiaoyun, et al.
Publicado: (2021)

Oncolytic Virotherapy as Emerging Immunotherapeutic Modality: Potential of Parvovirus H-1
por: Moehler, Markus, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_23cbk9n96b0e7ndhuoc0oqj2o1